# Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance

> **NCT07220694** · NA · RECRUITING · sponsor: **SF Research Institute, Inc.** · enrollment: 140 (estimated)

## Conditions studied

- Insulin Resistance
- Mild Cognitive Impairment
- Cognitive Decline
- Neurodegenerative Disorders

## Interventions

- **DIETARY_SUPPLEMENT:** Sabroxy®
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07220694
- **Lead sponsor:** SF Research Institute, Inc.
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-29
- **Primary completion:** 2026-03-28
- **Final completion:** 2026-04-29
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2026-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07220694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07220694, "Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07220694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*